Correlation Between Verve Therapeutics and MEI Pharma
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and MEI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and MEI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and MEI Pharma, you can compare the effects of market volatilities on Verve Therapeutics and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and MEI Pharma.
Diversification Opportunities for Verve Therapeutics and MEI Pharma
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Verve and MEI is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and MEI Pharma go up and down completely randomly.
Pair Corralation between Verve Therapeutics and MEI Pharma
Given the investment horizon of 90 days Verve Therapeutics is expected to generate 3.54 times more return on investment than MEI Pharma. However, Verve Therapeutics is 3.54 times more volatile than MEI Pharma. It trades about -0.08 of its potential returns per unit of risk. MEI Pharma is currently generating about -0.35 per unit of risk. If you would invest 594.00 in Verve Therapeutics on August 28, 2024 and sell it today you would lose (65.00) from holding Verve Therapeutics or give up 10.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verve Therapeutics vs. MEI Pharma
Performance |
| Timeline |
| Verve Therapeutics |
| MEI Pharma |
Verve Therapeutics and MEI Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verve Therapeutics and MEI Pharma
The main advantage of trading using opposite Verve Therapeutics and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
| MEI Pharma vs. Kezar Life Sciences | MEI Pharma vs. Vincerx Pharma | MEI Pharma vs. Avenue Therapeutics | MEI Pharma vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |